ArticleJournal of integrative plant biology2026
Coniferyl aldehyde from the phenylpropanoid pathway targets pyruvate kinase in Dactylobotrys graminicola to confer sheath rot resistance in hulless barley.
Article in Journal of integrative plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Coniferyl aldehyde from the phenylpropanoid pathway targets pyruvate kinase in Dactylobotrys graminicola to confer sheath rot resistance in hulless barley.Journal of integrative plant biology · 2026Article
- Metabolomic and Transcriptomic Responses ofPlants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dactylobotrys graminicola (Dgr), a necrotrophic fungal pathogen, has recently been identified as the causative agent of a novel sheath-rot disease in hulless barley, causing substantial reductions in yield and quality. Research has mainly focused on early detection and fungicide screening, while the resistance mechanisms in hulless barley remain poorly understood. This knowledge gap substantially impedes the breeding of resistant varieties and the development of environmentally sustainable control technologies. In this study, RNA sequencing and metabolomic analyses were conducted on hulless barley varieties exhibiting contrasting resistance to Dgr infection. These analyses revealed that the phenylpropanoid biosynthesis pathway was markedly upregulated in the resistant cultivar Z257. Notably, accumulation and secretion of coniferyl aldehyde (CA) were elevated in Z257 compared to the susceptible cultivar Z251. In vitro antifungal assays demonstrated that CA strongly inhibited Dgr growth. Drug affinity responsive target stability and microscale thermophoresis assays identified pyruvate kinase (PK) as CA's target. Molecular docking and enzymatic activity assays indicated that CA disrupts the binding of the substrate phosphoenolpyruvate to the active site of PK, reducing enzymatic activity. In conclusion, hulless barley enhances its resistance against Dgr by secreting CA, which inhibits the pathogen's PK, establishing an effective defense mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.